Susumu Maruta - Graduate School of Medicine, Chiba University

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 36 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Combination Therapy of Lenvatinib and Hepatic Arterial Infusion Chemotherapy Using Cisplatin with Lipiodol and 5-Fluorouracil: A Potential Breakthrough Therapy for Unresectable Advanced Hepatocellular Carcinoma

Susumu Maruta,Yohei Koshima, Takahiro Tsuchiya, Ryo Tamura,Masanori Takahashi,Tadashi Ohshima,Yoshihiko Ooka

CUREUS JOURNAL OF MEDICAL SCIENCEno. 8 (2024)

Cited0Views0WOSBibtex

Efficacy of Combination Therapy of Lenvatinib and New FP for the Treatment of Unresectable Advanced Hepatocellular Carcinoma: A Case Report

Susumu Maruta,Yohei Koshima, Taro Watabe, Ryo Tamura,Tadashi Ohshima,Masanori Takahashi,Yoshihiko Ooka

Kanzono. 9 (2024): 460-465

Cited0Views0Bibtex

Table S4 from A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: the LAUNCH Study

Kazufumi Kobayashi,Sadahisa Ogasawara,Susumu Maruta,Tomomi Okubo,Norio Itokawa,Yuki Haga,Yuya Seko, Michihisa Moriguchi,Shunji Watanabe,Yuki Shiko,Hirokazu Takatsuka,Hiroaki Kanzaki,Keisuke Koroki, Masatoshi Inoue,Masato Nakamura,Soichiro Kiyono,Naoya Kanogawa,Takayuki Kondo, Eiichiro Suzuki,Yoshihiko Ooka,Shingo Nakamoto,Yosuke Inaba,Masafumi Ikeda,Shinichiro Okabe,Naoki Morimoto,Yoshito Itoh,Kazuyoshi Nakamura,Kenji Ito,Ryosaku Azemoto,Masanori Atsukawa,Ei Itobayashi,Naoya Kato

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn